principal life insurance company health insurance
Cancer insurance policies, which are offered by private medical insurance (PMI) providers have been criticized for its lack of clarity and inclusion of terminology ambiguous, which can result in people being excluded from treatment and unclear of their rights, according to a study by Mercer and Cancerbackup, the cancer charity.
The study, called "Covering Cancer: Survey of Health Professionals / private health insurance providers, 11 providers interviewed key Britain's PMI to evaluate each of its principal policies of health insurance companies for cancer, including issues such as the scope and level of coverage, treatments included in the coverage and coverage limits.
Steve Clements, head of Mercer's health and benefits team, said: "One in three people in the UK will be diagnosed with cancer at some point in their lives. Some new treatments and sometimes expensive are now emerging as however, not available through the NHS. So, understandably, the coverage of cancer is an area of focus for private health care companies. "
He added: "PMI providers are using to differentiate themselves from competitors. While there have been improvements, there is continued ambiguity about what is and is not covered in some cases. Eligibility rules for chronic conditions, for example, can sometimes mean treatments cancer effectively be excluded or short. Transparency and clarity must be improved ".
Mr. Clements continued: "The new therapies are entering the market. Some of these will lead to long-term treatments where the goal is to curb the spread of the disease, prolong life or improve quality of life, alleviating the symptoms rather than cure. PMI providers must be clearer about whether they will be covered in their policies. "
The report also notes that PMI providers often use the term "active treatment" for cancer to govern their decisions on coverage of a particular course of treatment. This allows certain treatments to be covered for very specific reasons (eg radiotherapy to shrink a tumor), but others should be excluded (for example, current hormone therapy to control the spread and symptoms). The concept of active treatment is often only slightly explained in the document policy. Mercer also notes that the term is not currently recognized by the Association of British Insurers (ABI).
Derryn Borley, Head of Support Services for Cancer Cancerbackup, said: "It is not necessary to buy the most expensive cover but there should be absolute clarity about what is and is not covered. No arrangements should be clear and unflinching in place to transfer the management of private care in the public eye and again in private when necessary. Ultimately, the treatment of patients should not be compromised. The decisions of providers of PMI on whether certain treatments are covered or not taken case by case basis. There is a need to improve openness and transparency regarding the extension of coverage for cancer. People need to fully understand the term active treatment "when is used. "
According to the report, companies that seek to provide their employees with a level of uncompromising coverage should consider cancer Corporate AXA PPP Health 'Health, VIP and Executive Plan "with an optional cover cancer improved, BUPA Insurance policy and politics Premier Full PruHealth. These policies meet the 'Gold Standard'. The gold standard deck of cancer Cancerbackup is defined as the financing of all treatments intended to affect the growth of cancer to reduce cancer, stabilizing or reducing the spread of the disease and relieving symptoms.
Steve Clements also added: "There is a price attached to the" Gold Standard "and so other PMI policies are all options feasible for the health plans of companies in the right scenario. However, the buyer must be aware of the lower levels of cancer care coverage through of these policies.
Clements concluded: "It is vital that companies seek clarity PMI provider in many cases was achieved when employees reach the limit of its cover, but still need treatment, particularly if this treatment is not available through the NHS. Most PMI providers Respondents who have some flexibility about the coverage offered in this area, and thus may be able to offer customized solutions for customers can find the right balance between comprehensive coverage and accessibility.
About the Author:
Ruth is an author of several articles pertaining to Health Insurance. She is known for her expertise on the subject and on other Business and Finance related articles.
Article Source: ArticlesBase.com – Private Medical Insurers Unclear on Cancer Cover
Stop the insane democratic economic stimulus package.
